Pipeline Publications & Presentations

Migraine Manuscripts

Garnock-Jones, KP. "Sumatriptan Iontophoretic Transdermal System: A Review of Its Use in Patients with Acute Migraine." Drugs. 2013;73:1483-1490.

Jerome Goldstein, MD; Timothy R. Smith, MD, RPh, FACP; Neil Pugach, MD; Jim Griesser, MA; Terri Sebree, BS; Mark Pierce, MD, PhD. "A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine." Headache: The Journal of Head and Face Pain. 2012;52:1402-1410.

Timothy R. Smith, MD, RPh; Jerome Goldstein, MD; Richard Singer, MD; Neil Pugach, MD; Stephen Silbertein, MD; Mark Pierce, MD, PhD. "Twelve-Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System." Headache: The Journal of Head and Face Pain. 2012;52:612-624.

Mark Pierce, MD, PhD, Thomas Marbury, MD, Carol O'Neill, BA, Steven Siegel, MD, PhD, Wei Du, PhD, and Terri Sebree, BA. "Zelrix™: A Novel Transdermal Formulation of Sumatriptan." Headache: The Journal of Head and Face Pain." 2009; 49(6):817-825.

 

Migraine Presentations

Sumatriptan Transdermal System (TDS) Is Associated with Substantially Less Treatment Emergent Nausea Than Placebo
as presented at the International Headache Congress 2013, June 2013
Download PDF

Efficacy of the Sumatriptan Iontophoretic Transdermal System (TDS) is Similar in Migraine Patients With and Without Nausea at Baseline
as presented at the International Headache Congress 2013, June 2013
Download PDF

Sumatriptan Transdermal System (TDS) Can Be Correctly Assembled, Applied, and Activated During Migraine Attacks
as presented at the International Headache Congress 2013, June 2013
Download PDF

Long Term Safety of the Sumatriptan Iontophoretic Transdermal Patch, NP101, for Acute Migraine: A 12 Month, Repeat Use, Open Label Study
As presented at the 54th Annual Scientific Meeting of the American Headache Society (AHS), June 2012
Download PDF

A Phase I, Single Center, Open Label, Randomized Single-Dose, Two Way Crossover Study to Compare the Pharmacokinetics of Two NP101 Patch Applications (Sumatriptan Iontophoretic Transdermal System) with and without Controlled Heat
As presented at the 54th Annual Scientific Meeting of the American Headache Society (AHS), June 2012
Download PDF

Long-Term Safety and Efficacy of NP101, a Sumatriptan Iontophoretic Patch for the Acute Treatment of Migraine
As presented at the 15th Congress of the International Headache Society, June 2011
Download PDF

Long-Term Safety and Efficacy of NP101, a Sumatriptan Iontophoretic Patch for the Treatment of Acute Migraine
As presented at the 53rd Annual Scientific Meeting of the American Headache Society (AHS), June 2011
Download PDF

The Pharmacokinetics of the Sumatriptan Iontophoretic Transdermal System (NP101) in Elderly Versus Young Adults
As presented at the 53rd Annual Scientific Meeting of the American Headache Society (AHS), June 2011
Download PDF

Pharmacokinetic and Bioavailability Comparison Between NP101 Patches Used in a Phase III Clinical Study and Patches Intended for Commercial Use
As presented at the 53rd Annual Scientific Meeting of the American Headache Society (AHS), June 2011
Download PDF

Efficacy of Zelrix™, a Novel Iontophoretic Transdermal Sumatriptan Patch, in the Treatment of Acute Migraine in Patients With Nausea
As presented at the 52nd Annual Scientific Meeting of the American Headache Society (AHS), June 2010
Download PDF

Pharmacokinetics of Oral and Transdermal Sumatriptan During Acute Migraine and Non-Migraine Periods: Incidence of the Migraine Effect
As presented at the 52nd Annual Scientific Meeting of the American Headache Society (AHS), June 2010
Download PDF

Acute Anti-Migraine Efficacy and Tolerability of Zelrix™, a Novel Iontophoretic Transdermal Patch of Sumatriptan
As presented at the American Academy of Neurology (AAN) 62nd Annual Meeting, April 2010
Download PDF

Acute Anti-Migraine Efficacy and Tolerability of Zelrix™, a Novel Iontophoretic Transdermal Patch of Sumatriptan
As presented at the 14th Congress of the International Headache Society, September 2009
Download PDF

NP101: A Novel Formulation of Sumatriptan Succinate Utilizing SmartRelief™ Transdermal Technology
As presented at the 50th Annual Scientific Meeting of the American Headache Society (AHS), June 2008
Download PDF